Strata Skin Sciences Net Long-Term Debt 2010-2025 | SSKN

Strata Skin Sciences net long-term debt from 2010 to 2025. Net long-term debt can be defined as the net amount of long term debt issued and repaid. This field is either calculated as the sum of the long term debt fields or used if a company does not report debt issued and repaid separately
Strata Skin Sciences Annual Net Long-Term Debt
(Millions of US $)
2024 $N/A
2023 $7
2022 $N/A
2021 $0
2020 $3
2019 $0
2018 $-3
2017 $-1
2016 $2
2015 $43
2014 $15
2013 $-1
2012 $N/A
2011 $N/A
2010 $N/A
2009 $N/A
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.009B $0.034B
Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.919B 58.42
Doximity (DOCS) United States $11.317B 52.39
Hims & Hers Health (HIMS) United States $10.654B 110.70
Tempus AI (TEM) United States $10.042B 0.00
IRhythm Technologies (IRTC) United States $4.327B 0.00
Inspire Medical Systems (INSP) United States $3.691B 57.67
Hinge Health (HNGE) United States $3.687B 0.00
Privia Health (PRVA) United States $2.458B 168.00
Schrodinger (SDGR) United States $1.674B 0.00
Clover Health Investments (CLOV) United States $1.583B 0.00
Phreesia (PHR) United States $1.580B 0.00
Enovis (ENOV) United States $1.502B 8.38
Azenta (AZTA) United States $1.434B 66.64
10x Genomics (TXG) United States $1.421B 0.00
Omnicell (OMCL) United States $1.313B 23.17
Evolent Health (EVH) United States $1.146B 97.60
Claritev (CTEV) United States $0.705B 0.00
Fulgent Genetics (FLGT) United States $0.540B 0.00
Veradigm (MDRX) United States $0.498B 0.00
Standard BioTools (LAB) United States $0.479B 0.00
Butterfly Network (BFLY) United States $0.465B 0.00
Talkspace (TALK) United States $0.427B 127.50
TruBridge (TBRG) United States $0.337B 746.67
Outset Medical (OM) United States $0.310B 0.00
Nyxoah SA (NYXH) Belgium $0.270B 0.00
Health Catalyst (HCAT) United States $0.269B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.233B 0.00
CapsoVision (CV) United States $0.206B 0.00
Zepp Health (ZEPP) Netherlands $0.187B 0.00
KORU Medical Systems (KRMD) United States $0.160B 0.00
Pulmonx (LUNG) United States $0.128B 0.00
American Well (AMWL) United States $0.125B 0.00
MDxHealth SA (MDXH) Belgium $0.115B 0.00
EUDA Health Holdings (EUDA) Singapore $0.115B 0.00
CareCloud (CCLD) United States $0.100B 3.81
Insight Molecular Diagnostics (IMDX) United States $0.087B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.080B 0.00
111 (YI) China $0.066B 0.00
P3 Health Partners (PIII) United States $0.048B 0.00
HeartBeam (BEAT) United States $0.043B 0.00
Zhongchao (ZCMD) China $0.027B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Healthcare Triangle (HCTI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00